464 related articles for article (PubMed ID: 25243960)
1. [A randomized placebo-controlled multicentre study of Fuzhenghuayu capsule for prevention of oesophageal variceal bleeding in patients with liver cirrhosis].
Xiao D; Gu J; Cai H; Zhang Q; Xue D; Zhao C; Xu L
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):594-9. PubMed ID: 25243960
[TBL] [Abstract][Full Text] [Related]
2. Propranolol alone may not be acceptable to prevent first esophageal variceal bleeding in Japanese cirrhotic patients: randomized controlled trial.
Tomikawa M; Shimabukuro R; Okita K; Tsutsumi N; Akahoshi T; Hashizume M; Sugimachi K
J Gastroenterol Hepatol; 2004 May; 19(5):576-81. PubMed ID: 15086603
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding.
Sarin SK; Wadhawan M; Agarwal SR; Tyagi P; Sharma BC
Am J Gastroenterol; 2005 Apr; 100(4):797-804. PubMed ID: 15784021
[TBL] [Abstract][Full Text] [Related]
4. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.
Sarin SK; Lamba GS; Kumar M; Misra A; Murthy NS
N Engl J Med; 1999 Apr; 340(13):988-93. PubMed ID: 10099140
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis.
Lay CS; Tsai YT; Lee FY; Lai YL; Yu CJ; Chen CB; Peng CY
J Gastroenterol Hepatol; 2006 Feb; 21(2):413-9. PubMed ID: 16509867
[TBL] [Abstract][Full Text] [Related]
6. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
8. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.
Pascal JP; Cales P
N Engl J Med; 1987 Oct; 317(14):856-61. PubMed ID: 3306385
[TBL] [Abstract][Full Text] [Related]
9. Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation.
Gheorghe C; Gheorghe L; Iacob S; Iacob R; Popescu I
Hepatogastroenterology; 2006; 53(70):552-7. PubMed ID: 16995460
[TBL] [Abstract][Full Text] [Related]
10. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
[TBL] [Abstract][Full Text] [Related]
11. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
[TBL] [Abstract][Full Text] [Related]
12. Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding.
Luo X; Wang Z; Tsauo J; Zhou B; Zhang H; Li X
Radiology; 2015 Jul; 276(1):286-93. PubMed ID: 25759969
[TBL] [Abstract][Full Text] [Related]
13. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.
Burroughs AK; Jenkins WJ; Sherlock S; Dunk A; Walt RP; Osuafor TO; Mackie S; Dick R
N Engl J Med; 1983 Dec; 309(25):1539-42. PubMed ID: 6361553
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of digestive hemorrhage recurrence in hepatic cirrhosis with propranolol. A 4 years' follow-up study].
Jirón MI; Soto JR; Wolff C; Armas R
Rev Med Chil; 1993 Feb; 121(2):133-8. PubMed ID: 8303108
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.
Park DK; Um SH; Lee JW; Lee JB; Kim YS; Park CH; Jin YT; Chun HJ; Lee HS; Lee SW; Choi JH; Kim CD; Ryu HS; Hyun JH
J Gastroenterol Hepatol; 2004 Sep; 19(9):1042-51. PubMed ID: 15304123
[TBL] [Abstract][Full Text] [Related]
16. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: a multicenter, randomized clinical trial. The Italian Multicenter Project for Propranolol in Prevention of Bleeding.
Hepatology; 1988; 8(1):1-5. PubMed ID: 2892771
[TBL] [Abstract][Full Text] [Related]
17. Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding: a randomized-controlled trial.
Bonilha DQ; Lenz L; Correia LM; Rodrigues RA; de Paulo GA; Ferrari AP; Della Libera E
Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):84-90. PubMed ID: 25397691
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial.
Psilopoulos D; Galanis P; Goulas S; Papanikolaou IS; Elefsiniotis I; Liatsos C; Sparos L; Mavrogiannis C
Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1111-7. PubMed ID: 16148558
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
[TBL] [Abstract][Full Text] [Related]
20. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia.
Ohmoto K; Yamamoto S
Hepatogastroenterology; 2003; 50(54):1766-9. PubMed ID: 14696400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
